<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4414</id>
  <title>T3D4360</title>
  <common-name>Glycerol</common-name>
  <description>Glycerol is an important component of triglycerides (i.e. fats and oils) and of phospholipids. glycerol is a three-carbon substance that forms the backbone of fatty acids in fats. When the body uses stored fat as a source of energy, glycerol and fatty acids are released into the bloodstream. The glycerol component can be converted to glucose by the liver and provides energy for cellular metabolism.</description>
  <cas>56-81-5</cas>
  <pubchem-id>753</pubchem-id>
  <chemical-formula>C3H8O3</chemical-formula>
  <weight>92.09</weight>
  <appearance nil="true"/>
  <melting-point>20°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility>1000.0 mg/mL</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects>Chronically high levels of glycerol are associated with Glycerol Kinase Deficiency.</health-effects>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:34:10Z</created-at>
  <updated-at type="dateTime">2026-04-16T22:55:01Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Glycerol</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C00116</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>17522</chebi-id>
  <biocyc-id>GLYCEROL</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB04077</drugbank-id>
  <pdb-id>GOL</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OCC(O)CO</moldb-smiles>
  <moldb-formula>C3H8O3</moldb-formula>
  <moldb-inchi>InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2</moldb-inchi>
  <moldb-inchikey>PEDCQBHIVMGVHV-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">92.0938</moldb-average-mass>
  <moldb-mono-mass type="decimal">92.047344122</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Liquid</state>
  <logp>-1.76</logp>
  <hmdb-id>HMDB00131</hmdb-id>
  <chembl-id>CHEMBL692</chembl-id>
  <chemspider-id>733</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Tatsuro Tsuneno, Masaaki Takaku, &amp;#8220;Process for preparing boric esters of glycerol fatty acid esters.&amp;#8221; U.S. Patent US4515725, issued March, 1968.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003320</chemdb-id>
  <dsstox-id>DTXSID9020663</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00004097</susdat-id>
  <iupac>propane-1,2,3-triol</iupac>
</compound>
